About Scott Platshon
Form D filings for Ajax Therapeutics from 2021 to 2024 list Scott Platshon as director.
Scott Platshon first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Scott Platshon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Scott Platshon works with at each company, as listed on that company's latest Form D.
Ajax Therapeutics, Inc. · Form D, May 13, 2024